Francisco Jorge Batel Marques
AuthID: R-000-PGC
41
TITLE: Safety Profile of Sodium-Glucose Co-Transporter-2 (Sglt2) Inhibitors: A Retrospective Study of the Portuguese Pharmacovigilance System Database
AUTHORS: Mendes, D; Alves, C; Batel Marques, F;
PUBLISHED: 2018, SOURCE: 18th ISoP Annual Meeting on Pharmacovigilance without Borders in DRUG SAFETY, VOLUME: 41, ISSUE: 11
AUTHORS: Mendes, D; Alves, C; Batel Marques, F;
PUBLISHED: 2018, SOURCE: 18th ISoP Annual Meeting on Pharmacovigilance without Borders in DRUG SAFETY, VOLUME: 41, ISSUE: 11
INDEXED IN: WOS
42
TITLE: Statins and risk of cataracts: A systematic review and meta-analysis of observational studies Full Text
AUTHORS: Alves, C; Mendes, D ; Marques, FB;
PUBLISHED: 2018, SOURCE: CARDIOVASCULAR THERAPEUTICS, VOLUME: 36, ISSUE: 6
AUTHORS: Alves, C; Mendes, D ; Marques, FB;
PUBLISHED: 2018, SOURCE: CARDIOVASCULAR THERAPEUTICS, VOLUME: 36, ISSUE: 6
43
TITLE: A SYSTEMATIC REVIEW OF THE METHODOLOGICAL QUALITY OF ECONOMIC STUDIES EVALUATING OPHTHALMIC DRUGS Full Text
AUTHORS: Ribeiro, I; Batel Marques, FB; Alves, D; Alves, C;
PUBLISHED: 2018, SOURCE: VALUE IN HEALTH, VOLUME: 21
AUTHORS: Ribeiro, I; Batel Marques, FB; Alves, D; Alves, C;
PUBLISHED: 2018, SOURCE: VALUE IN HEALTH, VOLUME: 21
INDEXED IN: WOS
44
TITLE: Risk of Ophthalmic Adverse Effects in Patients Treated with MEK Inhibitors: A Systematic Review and Meta-Analysis
AUTHORS: Alves, C; Ribeiro, I; Penedones, A; Mendes, D ; Marques, FB;
PUBLISHED: 2017, SOURCE: OPHTHALMIC RESEARCH, VOLUME: 57, ISSUE: 1
AUTHORS: Alves, C; Ribeiro, I; Penedones, A; Mendes, D ; Marques, FB;
PUBLISHED: 2017, SOURCE: OPHTHALMIC RESEARCH, VOLUME: 57, ISSUE: 1
45
TITLE: Number needed to treat (NNT) in clinical literature: an appraisal Full Text
AUTHORS: Mendes, D ; Alves, C; Batel Marques, F;
PUBLISHED: 2017, SOURCE: BMC MEDICINE, VOLUME: 15, ISSUE: 1
AUTHORS: Mendes, D ; Alves, C; Batel Marques, F;
PUBLISHED: 2017, SOURCE: BMC MEDICINE, VOLUME: 15, ISSUE: 1
46
TITLE: A Cumulative Meta-Analysis Evaluating the Risk of Cataracts Associated with Statins Full Text
AUTHORS: Alves, C; Mendes, D ; Marques, FB;
PUBLISHED: 2017, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 26
AUTHORS: Alves, C; Mendes, D ; Marques, FB;
PUBLISHED: 2017, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 26
INDEXED IN: WOS
47
TITLE: Mortality and Cardiovascular Events Associated with DDP-4 Inhibitors: A Meta-Analysis of Observational Studies Full Text
AUTHORS: Alves, C; Mendes, D ; Marques, FB;
PUBLISHED: 2017, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 26
AUTHORS: Alves, C; Mendes, D ; Marques, FB;
PUBLISHED: 2017, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 26
INDEXED IN: WOS
48
TITLE: Application of the Number Needed to Treat (NNT) in Medical Literature: A Methodological Assessment Full Text
AUTHORS: Mendes, D ; Alves, C; Marques, FB;
PUBLISHED: 2017, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 26
AUTHORS: Mendes, D ; Alves, C; Marques, FB;
PUBLISHED: 2017, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 26
INDEXED IN: WOS
49
TITLE: Benefit-Risk of Therapies for Relapsing-Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis
AUTHORS: Diogo Mendes ; Carlos Alves; Francisco Batel Marques;
PUBLISHED: 2016, SOURCE: CNS DRUGS, VOLUME: 30, ISSUE: 10
AUTHORS: Diogo Mendes ; Carlos Alves; Francisco Batel Marques;
PUBLISHED: 2016, SOURCE: CNS DRUGS, VOLUME: 30, ISSUE: 10
50
TITLE: A systematic review of observational studies evaluating costs of adverse drug reactions Full Text
AUTHORS: Marques, FB; Penedones, A; Mendes, D; Alves, C;
PUBLISHED: 2016, SOURCE: ClinicoEconomics and Outcomes Research in CLINICOECONOMICS AND OUTCOMES RESEARCH, VOLUME: 8
AUTHORS: Marques, FB; Penedones, A; Mendes, D; Alves, C;
PUBLISHED: 2016, SOURCE: ClinicoEconomics and Outcomes Research in CLINICOECONOMICS AND OUTCOMES RESEARCH, VOLUME: 8
INDEXED IN: Scopus WOS Handle